Date published: 2025-10-2

1-800-457-3801

SCBT Portrait Logo
Seach Input

L189 (CAS 64232-83-3)

5.0(1)
Write a reviewAsk a question

See product citations (1)

Alternate Names:
6-Amino-2,3-dihydro-5-[(phenylmethylene)amino]-2-4(1H)-pyrimidineone; 6-amino-5-(benzylideneamino)-2-sulfanyl-4-pyrimidinol
Application:
L189 is a DNA ligase I, III and IV inhibitor
CAS Number:
64232-83-3
Purity:
≥95%
Molecular Weight:
246.29
Molecular Formula:
C11H10N4OS
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

L189 functions as a potent inhibitor targeting DNA ligases I, III, and IV, with half-maximal inhibitory concentrations (IC50) of 5, 9, and 5 µM respectively, demonstrating its efficacy in obstructing the activities of these critical enzymes involved in DNA repair and replication processes. It exhibits a pronounced affinity for DNA ligase I, with a binding constant (Ki) of 5 µM, indicating a strong inhibitory interaction that blocks the enzyme′s ability to bind DNA. L189 is particularly effective in disrupting the second step of the DNA ligation reaction, a pivotal phase where the DNA nick is sealed, thereby impeding the ligation process essential for DNA repair and replication continuity. Its mechanism of action is further highlighted by its ability to inhibit two fundamental pathways of DNA repair: base excision repair (BER), a key mechanism for repairing small lesions without altering the overall DNA structure, and non-homologous end joining (NHEJ), a critical pathway for repairing double-strand breaks.


L189 (CAS 64232-83-3) References

  1. SCR7 is neither a selective nor a potent inhibitor of human DNA ligase IV.  |  Greco, GE., et al. 2016. DNA Repair (Amst). 43: 18-23. PMID: 27235626
  2. Structure-activity relationships among DNA ligase inhibitors: Characterization of a selective uncompetitive DNA ligase I inhibitor.  |  Howes, TRL., et al. 2017. DNA Repair (Amst). 60: 29-39. PMID: 29078112
  3. The role of host DNA ligases in hepadnavirus covalently closed circular DNA formation.  |  Long, Q., et al. 2017. PLoS Pathog. 13: e1006784. PMID: 29287110
  4. Barley sodium content is regulated by natural variants of the Na+ transporter HvHKT1;5.  |  Houston, K., et al. 2020. Commun Biol. 3: 258. PMID: 32444849
  5. Base excision repair and its implications to cancer therapy.  |  Grundy, GJ. and Parsons, JL. 2020. Essays Biochem. 64: 831-843. PMID: 32648895
  6. Alternative Non-Homologous End-Joining: Error-Prone DNA Repair as Cancer's Achilles' Heel.  |  Caracciolo, D., et al. 2021. Cancers (Basel). 13: PMID: 33808562
  7. ROS induces NETosis by oxidizing DNA and initiating DNA repair.  |  Azzouz, D., et al. 2021. Cell Death Discov. 7: 113. PMID: 34001856
  8. Integrative analysis of therapy resistance and transcriptomic profiling data in glioblastoma cells identifies sensitization vulnerabilities for combined modality radiochemotherapy.  |  Schnöller, LE., et al. 2022. Radiat Oncol. 17: 79. PMID: 35440003
  9. Dimerization-dependent membrane tethering by Atg23 is essential for yeast autophagy.  |  Hawkins, WD., et al. 2022. Cell Rep. 39: 110702. PMID: 35443167
  10. Advance trends in targeting homology-directed repair for accurate gene editing: An inclusive review of small molecules and modified CRISPR-Cas9 systems.  |  Shams, F., et al. 2022. Bioimpacts. 12: 371-391. PMID: 35975201
  11. A Novel Seimatosporium and Other Sporocadaceae Species Associated with Grapevine Trunk Diseases in Cyprus.  |  Kanetis, LI., et al. 2022. Plants (Basel). 11: PMID: 36297757
  12. ROS and DNA repair in spontaneous versus agonist-induced NETosis: Context matters.  |  Azzouz, D. and Palaniyar, N. 2022. Front Immunol. 13: 1033815. PMID: 36426351

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

L189, 10 mg

sc-295349
10 mg
$220.00

L189, 50 mg

sc-295349A
50 mg
$750.00

What is the appearance of the compound?

Asked by: two2igm05
Thank you for your question. L189, sc-295349, is a light yellow to yellow solid.
Answered by: Chemical Support 4
Date published: 2017-04-14
  • y_2025, m_9, d_24, h_6CST
  • bvseo_bulk, prod_bvqa, vn_bulk_3.0.42
  • cp_1, bvpage1
  • co_hasquestionsanswers, tq_1
  • loc_en_US, sid_295349, prod, sort_[SortEntry(order=LAST_APPROVED_ANSWER_SUBMISSION_TIME, direction=DESCENDING)]
  • clientName_scbt
  • bvseo_sdk, java_sdk, bvseo-4.0.0
  • CLOUD, getContent, 102ms
  • QUESTIONS, PRODUCT
Rated 5 out of 5 by from Chen X; et alChen X; et al. (PubMed ID: 18451142) demonstrated that L189 is a competitive inhibitor with respect to nicked DNA, thus inhibiting DNA ligases I, III, and IV. -SCBT Publication Review
Date published: 2015-09-22
  • y_2025, m_9, d_24, h_6
  • bvseo_bulk, prod_bvrr, vn_bulk_3.0.42
  • cp_1, bvpage1
  • co_hasreviews, tv_0, tr_1
  • loc_en_US, sid_295349, prod, sort_[SortEntry(order=SUBMISSION_TIME, direction=DESCENDING)]
  • clientName_scbt
  • bvseo_sdk, java_sdk, bvseo-4.0.0
  • CLOUD, getReviews, 18ms
  • REVIEWS, PRODUCT
L189 is rated 5.0 out of 5 by 1.
  • y_2025, m_9, d_24, h_6
  • bvseo_bulk, prod_bvrr, vn_bulk_3.0.42
  • cp_1, bvpage1
  • co_hasreviews, tv_0, tr_1
  • loc_en_US, sid_295349, prod, sort_[SortEntry(order=SUBMISSION_TIME, direction=DESCENDING)]
  • clientName_scbt
  • bvseo_sdk, java_sdk, bvseo-4.0.0
  • CLOUD, getAggregateRating, 104ms
  • REVIEWS, PRODUCT